Tarsus Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2019 to Q4 2023.
  • Tarsus Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $0.000.
  • Tarsus Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $0.000.
  • Tarsus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Tarsus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$4K, a 107% decline from 2021.
  • Tarsus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $55K, a 5400% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $0 $0 +$5K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$5K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$5K $0 -$1K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$4K $0 -$54K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $50K -$5K +$336K +98.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$286K $0 -$29K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$257K $1K -$312K -99.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $55K $54K +$54K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $1K -$341K -$342K -34200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $343K $29K +$29K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $314K $313K +$313K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1K $0 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1K +$1K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.